SUMO-Activating Enzyme Subunit 1 Is Associated with Poor Prognosis, Tumor Progression, and Radio-Resistance in Colorectal Cancer.

Wu, Yueh-Jung; Huang, Siang-Ting; Chang, Ya-Hui; Lin, Shih-Yi; Lin, Weng-Ling; Chen, Ying-Jung; Chien, Shang-Tao

Wu, Yueh-Jung; Huang, Siang-Ting; Chang, Ya-Hui; Lin, Shih-Yi; Lin, Weng-Ling; Chen, Ying-Jung; Chien, Shang-Tao.

Afiliación

Wu YJ; Division of Colorectal Surgery, Kaohsiung Armed Forces General Hospital, Kaohsiung 802, Taiwan.
Huang ST; Cancer Center, Kaohsiung Armed Forces General Hospital, Kaohsiung 802, Taiwan.
Chang YH; Cancer Center, Kaohsiung Armed Forces General Hospital, Kaohsiung 802, Taiwan.
Lin SY; Department of Pathology, Kaohsiung Armed Forces General Hospital, Kaohsiung 802, Taiwan.
Lin WL; Department of Pathology, Kaohsiung Armed Forces General Hospital, Kaohsiung 802, Taiwan.
Chen YJ; Department of Fragrance and Cosmetic Science, Kaohsiung Medical University, Kaohsiung 807, Taiwan.
Chien ST; Department of Pathology, Kaohsiung Armed Forces General Hospital, Kaohsiung 802, Taiwan.

Curr Issues Mol Biol ; 45(10): 8013-8026, 2023 Sep 30.

Article en En | MEDLINE | ID: mdl-37886949

Palabras clave

SAE1; biomarker; chemoradiotherapy; colorectal carcinoma; prognosis

Texto completo

Imprimir

XML

PubMed Links

Buscar en Google

Texto completo: 1 Colección: 01-internacional Banco de datos: MEDLINE Idioma: En Revista: Curr Issues Mol Biol Asunto de la revista: BIOLOGIA MOLECULAR Año: 2023 Tipo del documento: Article País de afiliación: Taiwán

Texto completo

Imprimir

XML

PubMed Links

Buscar en Google